GreenRoc Accelerates their World Class Project to Production as Early as 2028. Watch the full video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHeiq Regulatory News (HEIQ)

Share Price Information for Heiq (HEIQ)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 13.00
Bid: 13.05
Ask: 14.95
Change: 1.00 (7.69%)
Spread: 1.90 (14.559%)
Open: 13.00
High: 13.00
Low: 13.00
Prev. Close: 13.00
HEIQ Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Notice of AGM

13 May 2021 07:00

RNS Number : 4485Y
HeiQ PLC
13 May 2021
 

13 May 2021

 

HeiQ Plc

("HeiQ" or "the Company")

 

Notice of AGM

 

HeiQ Plc (LSE:HEIQ), an established global brand in materials and textile innovation that operates in high-growth markets, provides notice of its Annual General Meeting ("AGM") which will be held on Friday 25 June 2021 at 10.00 a.m. BST at Ruetistrasse 12 8952 Schlieren (Zurich) Switzerland, with a satellite meeting place at the offices of Charles Russell Speechlys LLP, 5 Fleet Place, London EC4M 7RD.

 

In respect to the satellite meeting in the UK, as the AGM is being held after the date on which the UK government's COVID-19 restrictions are due to be fully lifted it is currently anticipated that shareholders, proxies and corporate representatives will be able to attend and participate in the Meeting, adhering to social distancing rules. Further details on arrangements regarding both meetings can be found in the Notice of AGM.

 

The Company's Annual Report and Accounts for the year ended 30 December 2020 and the Notice of AGM are available to view on HeiQ's website, www.heiq.com/investors. A copy of the Annual Report and Notice of AGM will shortly be submitted to the Financial Conduct Authority in the United Kingdom via the National Storage Mechanism and will be available for inspection shortly at https://data.fca.org.uk/#/nsm/nationalstoragemechanism. Copies will be posted to shareholders, together with a form of proxy, on 19 May 2021.

 

For further information, please contact:

HeiQ Plc

Carlo Centonze (CEO)

+41 56 250 68 50

Arlington Group Asset Management Limited (Financial Advisor and Joint Broker)

Charles Cannon Brookes

 

+44 (0) 207 389 5017

Cenkos Securities plc (Joint Broker)

Stephen Keys / Callum Davidson

 

+44 (0) 207 397 8900

SEC Newgate (Media Enquiries)

Elisabeth Cowell / Robin Tozer / Megan Kovach

+44 (0) 20 3757 6882

HeiQ@secnewgate.co.uk

 

About HeiQ

HeiQ is a pioneer and at the forefront of global technology in the $10 billion antimicrobial fabrics and $24 billion textile chemicals market. With the focus on materials and textile innovation, HeiQ has created some of the most effective, durable and high-performance technologies and textile effects in the market today, which cool, warm, dry, repel, purify, and destroy viruses. Since 2005, HeiQ has developed over 200 technologies in partnership with 300 major brands.

HeiQ is a high intellectual capital company which has successfully built up a reputation in textile technologies, having won multiple awards and innovating with leading eco-conscious brands such as Patagonia.

Led by an experienced management team, HeiQ rapidly researches new solutions for partners, quickly delivers scale up manufacturing from its sites across the world and helps partners market the product to end consumers - aiming for lab to consumer in months.

HeiQ aims to deliver growth for its shareholders through a combination of increased sales of its core products and by entering additional lucrative markets through disruptive innovations.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NOAUUVNRAUUVAAR
12
Date   Source Headline
28th Apr 20227:00 amRNSResults for the year ended 31 December 2021
14th Apr 20227:00 amRNSFY 2021 Trading Update and Notice of Results
24th Feb 20222:55 pmRNSIssue of Equity
17th Feb 20222:35 pmRNSDirector/PDMR Shareholding
14th Feb 20227:00 amRNSHUGO BOSS and LYCRA back new climate positive yarn
3rd Dec 20217:00 amRNSInvestor Presentation
28th Sep 20219:05 amRNSSecond Price Monitoring Extn
28th Sep 20219:00 amRNSPrice Monitoring Extension
28th Sep 20217:00 amRNSInterim Results
20th Sep 20217:00 amRNSNotice of Results and Investor Presentation
16th Jul 20217:00 amRNSCollaboration Agreement with The LYCRA Company
9th Jul 20217:00 amRNSCompletion of Acquisition
28th Jun 20211:45 pmRNSFurther re. Annual General Meeting
25th Jun 20214:40 pmRNSResult of AGM
21st Jun 20214:30 pmRNSAnnual General Meeting Update
15th Jun 20217:00 amRNSAcquisition Life Material Technologies Limited
9th Jun 20217:00 amRNSHeiQ Chrisal water treatment solution contract win
28th May 20217:00 amRNSCreates sustainable textile finishing partnership
20th May 20214:20 pmRNSProgressive initiates coverage
13th May 20217:00 amRNSNotice of AGM
29th Apr 20217:00 amRNSAcquisition of RAS AG
28th Apr 20217:00 amRNSResults for the year ended December 31, 2020
8th Apr 20217:00 amRNSNotice of Results and Investor Presentation
19th Mar 20217:00 amRNSHeiQ Viroblock Agreement with ICP
11th Mar 20217:00 amRNSHeiQ Viroblock Partnership with Berger Paint
3rd Mar 20217:00 amRNSAcquisition of 51% of Industrial Biotech Business
11th Feb 20217:00 amRNSHeiQ Viroblock Contract Win
28th Jan 202111:30 amRNSLaunch of HeiQ Viroblock Permanent
27th Jan 20219:05 amRNSSecond Price Monitoring Extn
27th Jan 20219:00 amRNSPrice Monitoring Extension
26th Jan 20219:05 amRNSSecond Price Monitoring Extn
26th Jan 20219:00 amRNSPrice Monitoring Extension
26th Jan 20217:00 amRNSTrading Update
13th Jan 20217:00 amRNSChange of External Auditor
5th Jan 20212:01 pmRNSPrice Monitoring Extension
4th Jan 20219:05 amRNSSecond Price Monitoring Extn
4th Jan 20219:00 amRNSPrice Monitoring Extension
15th Dec 20207:00 amRNSMajority stake in medical device manufacturer
9th Dec 202011:15 amRNSDirector/PDMR Dealings
9th Dec 20207:00 amRNSInvestor Presentation
7th Dec 20208:00 amRNSAdmission to Trading and First Day of Dealings
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.